Manipulation of oxygen tensions for in vitro cell culture using a hypoxic workstation

Expert Review of Proteomics

Volumn 2, Issue 3, 2005, Pages 307-314

  Esteban, Miguel A ^a   Maxwell, Patrick H ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Hydroxylation; Hypoxia; Hypoxia inducible factor; Oxygen; Prolyl hydroxylase domain enzymes; Ubiquitylation; Von Hippel Lindau

Indexed keywords

CARBONATE DEHYDRATASE; CHEMOKINE RECEPTOR CXCR4; COBALT COMPLEX; CYCLIN D1; CYTOKERATIN 14; ENOLASE; ERYTHROPOIETIN; FIBRONECTIN; GELATINASE A; GLUCOSE TRANSPORTER 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; IRON CHELATE; LACTATE DEHYDROGENASE; MULTIDRUG RESISTANCE PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN BNIP3; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN KINASE; SCATTER FACTOR RECEPTOR; SOMATOMEDIN B; STROMAL CELL DERIVED FACTOR 1; TRANSFERRIN; TRANSFERRIN RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN; VIMENTIN;

AEROBIC METABOLISM; AMBIENT AIR; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RESPIRATION; CELL VIABILITY; ENZYME MECHANISM; EQUIPMENT; GENE EXPRESSION; GENE TARGETING; HYDROXYLATION; HYPOXIC CELL; IN VITRO STUDY; OXIDATIVE STRESS; OXYGEN TENSION; OXYGENATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANOXIA; CELL CULTURE TECHNIQUES; CELL HYPOXIA; CELLS, CULTURED; CHELATING AGENTS; GENE EXPRESSION REGULATION; HYDROXYLATION; OXYGEN; PROTEINS;

EID: 20544463831     PISSN: 14789450     EISSN: None     Source Type: Journal    
DOI: 10.1586/14789450.2.3.307     Document Type: Review

References (59)

1. Gnaiger E. Oxygen conformance of cellular respiration. A perspective of mitochondrial physiology. Adv. Exp. Med. Biol. 543, 39-55 (2003).
2. Nohl H, Kozlov AV, Gille L, Staniek K. Cell respiration and formation of reactive oxygen species: facts and artefacts. Biochem. Soc. Trans. 31(6), 1308-1311 (2003).
3. Gnaiger E. Bioenergetics at low oxygen: dependence of respiration and phosphorylation on oxygen and adenosine diphosphate supply. Respir. Physiol. 128(3), 277-297 (2001)
4. Lenaz G, Bovina C, D'Aurelio M et al. Role of mitochondria in oxidative stress and aging. Ann. NY Acad. Sci. 959, 199-213 (2002).
5. Mercurio F, Manning AM. NF-κB as a primary regulator of the stress response. Oncogene 18(45), 6163-6171 (1999).
6. Dewhirst MW, Secomb TW, Ong ET, Hsu R, Gross JF. Determination of local oxygen consumption rates in tumors. Cancer Res. 54(13), 3333-3336 (1994).
7. Maxwell P. HIF-1: an oxygen response system with special relevance to the kidney. J. Am. Soc. Nephrol. 14(11), 2712-2722 (2003).
8. Olson EE, McKeon RJ. Characterization of cellular and neurological damage following unilateral hypoxia/ischaemia. J. Neurol. Sci. 227(1), 7-19 (2004).
9. Walmsley SR, Print C, Farahi N et al. Hypoxia-induced neutrophil survival is mediated by HIF-1α-dependent NF-κB activity. J. Exp. Med. 201(1), 105-115 (2005).
10. 2 consumption in monolayer cell cultures. Respir. Physiol. 100(2), 101-106 (1995). One of the first articles to address the problem of oxygen diffusion/consumption in conventional cultures.
11. Sheta EA, Trout H, Gildea JJ, Harding MA, Theodorescu D. Cell density mediated pericellular hypoxia leads to induction of HIF-1α via nitric oxide and Ras/MAPK mediated signaling pathways. Oncogene 20(52), 7624-7634 (2001).
12. Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S, Campisi J. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nature Cell Biol. 5(8), 741-747 (2003). A clear example that some cell types proliferate better under low oxygen tensions.
13. Liu L, Simon MC. Regulation of transcription and translation by hypoxia. Cancer Biol. Ther. 3(6), 492-497 (2004).
14. Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 88(4), 1474-1480 (2000).
15. Maxwell PH, Pugh CW, Ratcliffe PJ. Activation of the HIF pathway in cancer. Curr. Opin. Genet. Dev. 11(3), 293-299 (2001).
16. Semenza GL, Agani F, Feldser D et al. Hypoxia, HIF-1, and the pathophysiology of common human diseases. Adv. Exp. Med. Biol. 475, 123-130 (2000).
17. Cramer T, Yamanishi Y, Clausen BE, Forster I et al. HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112(5), 645-657 (2003). Provides evidence of an essential role of hypoxia-inducible factor (HIF)-1 in inflammatory responses.
18. Melillo G. HIF-1: a target for cancer, ischaemia and inflammation - too good to be true? Cell Cycle 3(2), 154-155 (2004).
19. Jiang H, Guo R, Powell-Coffman JA. The Caenorhabditis elegans hif-1 gene encodes a bHLH-PAS protein that is required for adaptation to hypoxia. Proc. Natl Acad. Sci. USA 98(14), 7916-7921 (2001).
20. Jewell UR, Kvietikova I, Scheid A, Bauer C, Wenger RH, Gassmann M. Induction of HIF-1α in response to hypoxia is instantaneous. FASEB J. 15(7), 1312-1314 (2001). The induction of HIF in hypoxia is almost instantaneous.
21. 2-regulated prolyl hydroxylation. Science 292(5516), 468-472 (2001). Identifies prolyl hydroxylation as the main determinant for the control of HIF stability.
22. 2 sensing. Science 292(5516), 464-468 (2001). Identifies prolyl hydroxylation as the main determinant for the control of HIF stability.
23. Epstein AC, Gleadle JM, McNeill LA et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107(1), 43-54 (2001). Identifies the dioxygenases that regulate HIF by prolyl hydroxylation.
24. Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294(5545), 1337-1340 (2001). Identifies the dioxygenases that regulate HIF by prolyl hydroxylation.
25. Maxwell PH, Wiesener MS, Chang GW et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399(6733), 271-275 (1999). First article describing that HIF is constitutively stabilized in von Hippel-Lindau (VHL)-negative renal cancer cells, which provided the basis for the ulterior identification of VHL as part of a complex with ubiquitin ligase activity.
26. Cockman ME, Massen N, Mole DR et al. Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 275(33), 25733-25741 (2000).
27. Salceda S, Caro J. Hypoxia-inducible factor-1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272(36), 22642-22647 (1997).
28. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16(12), 1466-1471 (2002). Unveils the role of factor-inhibiting HIF (FIH) as another hydroxylating enzyme that acts on an asparragine residue in the C-terminal part of HIFα.
29. Hewitson KS, McNeill LA, Riordan MV et al. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277(29), 26351-26355 (2002). Unveils the role of FIH as another hydroxylating enzyme that acts on an asparragine residue in the C-terminal part of HIFα.
30. Stolze IP, Tian YM, Appelhoff RJ et al. Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (HIF) in regulating HIF transcriptional target genes. J. Biol. Chem. 279(41), 42719-42725 (2004).
31. Koivunen P, Hirsila M, Gunzler V, Kivirikko KI, Myllyharju J. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J. Biol. Chem. 279(11), 9899-9904 (2004).
32. del Peso L, Castellanos MC, Temes E et al. The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen. J. Biol. Chem. 278(49), 48690-48695 (2003).
33. Brahimi-Horn C, Mazure N, Pouyssegur J. Signalling via the hypoxia-inducible factor-1α requires multiple posttranslational modifications. Cell Signal. 17(1), 1-9 (2005).
34. Hewitson KS, McNeill LA, Schofield CJ. Modulating the hypoxia-inducible factor signaling pathway: applications from cardiovascular disease to cancer. Curr. Pharm. Des. 10(8), 821-833 (2004).
35. Jeong JW, Bae MK, Ahn MY et al. Regulation and destabilization of HIF-1α by ARD1-mediated acetylation. Cell 111(5), 709-720 (2002).
36. Fisher T, Etages SD, Hayes L, Crimin K, Li B. Analysis of ARD1 function in hypoxia response using retroviral RNA interference. J. Biol. Chem. 280(18), 17749-17757 (2005).
37. Chan DA, Sutphin PD, Denko NC, Giaccia AJ. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1α. J. Biol. Chem. 277(42), 40112-40117 (2002).
38. Brugarolas J, Lei K, Hurley RL et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 18(23), 2893-2904 (2004).
39. Brugarolas JB, Vazquez F, Reddy A, Sellers WR, Kaelin WG Jr. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell 4(2), 147-158 (2003).
40. Yin K, Juurlink BH. Regulation of expression of nuclear factor κB RelA in oligodendrocytes: effect of hypoxia. Neuroreport 11(9), 1877-1881 (2000).
41. Matsushita H, Morishita R, Nata T et al. Hypoxia-induced endothelial apoptosis through nuclear factor-κB (NF-κB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-κB in endothelial cell regulation. Circ. Res. 86(9), 974-981 (2000).
42. Samuni AM, Kasid U, Chuang EY et al. Effects of hypoxia on radiation-responsive stress-activated protein kinase, p53, and caspase 3 signals in TK6 human lymphoblastoid cells. Cancer Res. 65(2), 579-586 (2005).
43. Sanchez-Puig N, Veprintsev DB, Fersht AR. Binding of natively unfolded HIF-1α ODD domain to p53. Mol. Cell 17(1), 11-21 (2005).
44. Kuznetsova AV, Meller J, Schnell PO et al. von Hippel-Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination. Proc. Natl Acad. Sci. USA 100(5), 2706-2711 (2003).
45. Lopez-Barneo J. Oxygen and glucose sensing by carotid body glomus cells. Curr. Opin. Neurobiol. 13(4), 493-499 (2003).
46. Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270(3), 1230-1237 (1995).
47. Wang GL, Semenza GL. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82(12), 3610-3615 (1993).
48. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nature Rev. Mol. Cell Biol. 5(5), 343-354 (2004). Summarizes the current knowledge about cellular responses to hypoxia and discusses the possibility of a wider role for post-translational hydroxylation in signaling.
49. Ratan RR, Siddiq A, Aminova L et al. Translation of ischemic preconditioning to the patient: prolyl hydroxylase inhibition and hypoxia inducible factor-1 as novel targets for stroke therapy. Stroke 35(11 Suppl. 1), 2687-2689 (2004).
50. Ratcliffe PJ, Pugh CW, Maxwell PH. Targeting tumors through the HIF system. Nature Med. 6(12), 1315-1316 (2000).
51. Hewitson ICS, Schofield CJ. The HIF pathway as a therapeutic target. Drug Discov. Today 9(16), 704-711 (2004).
52. Mastyugin V, Mezentsev A, Zhang WX, Ashkar S, Dunn MW, Laniado-Schwartzman M. Promoter activity and regulation of the corneal CYP4B1 gene by hypoxia. J. Cell. Biochem. 91(6), 1218-1238 (2004).
53. Yang ZZ, Zou AP. Transcriptional regulation of heme oxygenases by HIF-1α in renal medullary interstitial cells. Am. J. Physiol. Renal Physiol. 281(5), F900-F908 (2001).
54. Jung F, Palmer LA, Zhou N, Johns RA. Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ. Res. 86(3), 319-325 (2000).
55. Hofbauer KH, Gess B, Lohaus C, Meyer HE, Katschinski D, Kurtz A. Oxygen tension regulates the expression of a group of procollagen hydroxylases. Eur. J. Biochem. 270(22), 4515-4522 (2003).
56. Demasi M, Cleland LG, Cook-Johnson RJ, James MJ. Effects of hypoxia on the expression and activity of cyclooxygenase-2 in fibroblast-like synoviocytes: interactions with monocyte-derived soluble mediators. Arthritis Rheum. 50(8), 2441-2449 (2004).
57. Metzen E, Stiehl DP, Doege K, Marxsen JH, Hellwig-Burgel T, Jelkmann W. Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive element. Biochem. J. 387(Pt 3), 711-717 (2004).
58. Moukarbel GV, Ayoub CM, Abchee AB. Pharmacological therapy for myocardial reperfusion injury. Curr. Opin. Pharmacol. 4(2), 147-153 (2004).
59. Becker LB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc. Res. 61(3), 461-470 (2004).